Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion - Implications for iNOS-mediated myocardial stunning

Thoracic and Cardiovascular Surgeon

Volumn 47, Issue 3, 1999, Pages 137-143

  Wildhirt, Stephen M ^a   Schulze, C ^a   Conrad, N ^a   Kornberg, A ^a   Horstman, D ^b   Reichart, B ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Aminoguanidine; Inducible nitric oxide synthase; Lschemia; Myocardial blood flow; Myocardial stunning; Reperfusion

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; CORONARY ARTERY DILATATION; EXTRACORPOREAL CIRCULATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; STUNNED HEART MUSCLE;

EID: 0032765687     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013128     Document Type: Article

References (47)

1. Hansen P. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 1995;91 : 1872-85.
2. Lefer A, Lefer D. The role of nitric oxide and cell adhesion-molecules on the microcirculation in ischemia-reperfusion. Cardiovasc Res. 1996;32 : 743-51.
3. Yasmin W, Strynadka K, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res. 1997;33 : 422-32.
4. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia-reperfusion injury. Cardiovasc Res. 1995;30 : 432-9.
5. Finkel M, Oddis C, Jacob T, Watkins S, Hattler B, Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257 : 387-9.
6. Wildhirt S, Suzuki H, Horstman D, Weismueller S, Dudek R, Akiyama K, Reichart B. Selective Modulation of inducible nitric oxide synthase in myocardial infarction. Circulation. 1997;96 : 1616-23.
7. Worral N, Chang K, Suau G, et al. Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection. Circ Res. 1996;78 : 769-79.
8. Hiroe M, Ishiyama S, Nishikawa T, Shimojo T, Ito H, Kasajima T, Marumo F. Expression of inducible nitric oxide synthase in the myocardium of acute myocarditis - a serial cardiac biopsy study. J Am Coll Cardiol. 1995; Special Issue : 131A.
9. Ishiyama S, Hiroe M, Nishikawa T, et al. Nitric oxide contributes to the progression of myocardial damage in experimental myocarditis in rats. Circulation. 1997;95 : 489-96.
10. Radomski M, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovascular Research. 1993;27 : 1380-2.
11. Weyrich A, Ma X, Lefer A. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;86 : 279-88.
12. Hiramatsu T, Forbess J, Miura T, Mayer J. Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. J Thorac Cardiovasc Surg. 1995;109 : 81-7.
13. Nakanishi K, Vinten-Johannsen J, Lefer D, Zhao Z, Fowler III W, McGee D, Johnston W. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J of Physiol. 1992;263 : H1650-8.
14. Amrani M, Chester A, Jayakumar J, Schyns C, Yacoub M. L-arginine reverses low coronary reflow and enhances postischemic recovery of cardiac mechanical function. Cardiovasc Res. 1995;30 : 432-9.
15. Hasebe N, Shen Y, Vatner S. Inhibition of endothelium derived relaxing factor enhances myocardial stunning in concious dogs. Circulation. 1993;88 : 2862-71.
16. Woolfson R, Patel V, Neild G, Yellon D. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 1995;91 : 1545-51.
17. Patel V, Yellon D, Singh K, Neild G, Woolfson R. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Comm. 1993;194 : 234-8.
18. Matheis G, Sherman M, Buckberg G, Hayborn D, Young H, Ignarro L. Role of L-arginine nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol. 1992;262 : 616-20.
19. Mitchell M, Winter C, Banerjee A. The relationship between ischemia-reperfusion injury, myocardial stunning and cardiac preconditioning. Surg Gyn Obst. 1993;177 : 97-114.
20. Mori E, Haramaki N, Ikeda H, Imaizumi T. Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc Res. 1998;40 : 113-23.
21. Takeuchi K, McGowan F, Danh H, Glunn P, Simplaceanu E, del Nido P. Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to myocardium. J Mol Cell Cardiol. 1995; 27 : 1405-14.
22. Wildhirt S, Suzuki H, Wolf W, Dudek R, Horstman D, Weismueller S, Reichart B. S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. Biochem Biophys Res Comm. 1996;227 : 328-33.
23. Glenny R, Bernard S, Brinkley M. Validation of fluorescent labeled microspheres for measurement of regional organ perfusion. J Appl Physiol. 1993;74 : 2585-97.
24. Bredt D, Snyder S. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc Nat Acad Sci. 1989;87 : 682-5.
25. 2+-independent nitric oxide synthase in the myocardium. Brit J Pharm. 1992;105 : 575-80.
26. Yang X, Chowdhury N, Cai B, Marboe C, Sciacca R, Michler R, Cannon P. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest. 1994;94 : 714-21.
27. Russel M, Wallace A, Wyner L, Newell J, Karnovsky M. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 1995;92 : 457-64.
28. Worrall N, Lazenby W, Misko T, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exper Med. 1995;181 : 63-70.
29. Hirono S, Islam M, Nakazawa M, Yoshida Y, Kodama M, Shibata A, Izumi T, Imai S. Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res. 1997;80 : 11-20.
30. Schulz R, Panas D, Catena R, Moncada S, Olley P, Lopaschuk G. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor alpha. Brit J Pharm. 1995;114 : 27-34.
31. Smith J, Radomsky M, Schulz R, Moncada S, Lewis M. Porcine ventricular endothelial cells in culture express the inducible form of nitric oxide synthase. Brit J Pharm. 1993;108 : 1107-10.
32. Balligand J, Cannon P. Nitric oxide syntheses in cardiac muscle. Arterioscl Throm Vasc Biol. 1997;17 : 1846-58.
33. Hare J, Givertz M, Ma C, Colucci W. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure. Potentiation of β-adrenergic inotropic responsiveness. Circulation. 1998;97 : 161-6.
34. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury. Shock. 1996; 6 : 79-88.
35. Buttery L, Springall D, Chester A, Evans T, Standfield N, Parums D, Yacoub M, Polak J. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75 : 77-85.
36. Liu P, Hock C, Nagele R, Wong P. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol. 1997;272 : H2327-36.
37. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused myocardium. Circul Res. 1996;79 : 949-56.
38. Suzuki H, Wildhirt S, Dudek R, Narayan K, Bailey A, Bing R. Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages. Tiss and Cell. 1996;28 : 89-97.
39. Szabolcs M, Ravalli S, Minanov O, Sciacca R, Michler R, Cannon P. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation. 1998;65 : 804-12.
40. Drexler H, Hablawetz E, Lu W, Riede U, Christes A. Effects of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation. 1992;86 : 255-62.
41. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. J Clin Invest. 1993;92 : 652-62.
42. Zeiher AM, Krause T, Schaechtinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 1995;91 : 2345-52.
43. Casino P, Kilcoune C, Quyyumi A, Hoeg J, Panza J. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol 1994;23 : 844-50.
44. Jun T, Wennmalm A. L-Arginine-induced hypotension in the rat: evidence that NO synthesis is not involved. Acta Physiol Scand. 1994;152 : 385-90.
45. Liu P, Hock C, Nagele R, Wong P. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol. 1997;272 : H2327-36.
46. Parrino P, Laubach V, Gaughen J, et al. Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow. Ann Thorac Surg. 1998;66 : 733-9.
47. Wildhirt S, Conrad N, Kuehnapfel S, Schulze C, Kornberg A, Reichart B. Improvement of coronary vasomotor function by mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase in isolated rat hearts. Circulation. 1998;97 (Suppl. 1) : 668.